LETKO, BROSSEAU & ASSOCIATES INC
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1297496
MONTREAL, A8
Position in NAMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$321,107
-$55,810 QoQ
Shares Held
9,475
-19.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 197 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LETKO, BROSSEAU & ASSOCIATES INC holds $55,170,971 across 18 Biotechnology names. NAMS ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
724,830 | $50,759,844 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
3,500 | $534,870 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
9,600 | $487,200 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
32,000 | $432,320 | |
| 5 | GHRS |
GH Research PLC
|
15,425 | $414,624 | |
| 6 | BCAX |
Bicara Therapeutics Inc.
|
11,175 | $331,785 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
9,475 | $321,107 | |
| 8 | SPRY |
ARS Pharmaceuticals, Inc.
|
40,050 | $320,800 |
All Filings in NAMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $321,107 | 9,475 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $376,917 | 11,775 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $413,067 | 11,775 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $334,881 | 11,775 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $213,245 | 11,775 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||